PMV Pharmaceuticals, Inc. (PMVP) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 65.68M |
| Enterprise Value | 28.53M |
| P/E Ratio | -0.96 |
| PEG Ratio | -0.1 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 1.02 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.79 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -0.92 |
| Return On Equity | -0.78 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -79.78M |
| Net Income | -77.74M |
| Diluted EPS | -1.48 |
Balance Sheet
| Total Cash | 79.43M |
| Total Cash/Share | 1.49 |
| Total Debt | 217,000 |
| Total Debt/Equity | 0 |
| Current Ratio | 7.7 |
| Book Value Per Share | 1.34 |
Price History
| 52-Week Change | -11.69 |
| 52-Week High | 1.91 |
| 52-Week Low | 1.02 |
| Moving Average 50 Days | 1.38 |
| Moving Average 200 Days | 1.3 |
Statistics
| Average Volume | 660,976 |
| Shares Outstanding | 53.33M |
| % Held by Institutions | 64.21 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
